Cited by 538Antifungal resistance and susceptibilityFungal Infections and StudiesAntibiotics Pharmacokinetics and Efficacy

The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

Open access

Stone, Neil R. H., Bicanic, Tihana, Salim, Rahuman, Hope, William·2016·Drugs

DOI 10.1007/s40265-016-0538-7PMC PMC4856207

Open this paper in CoChat — free account

Abstract

Liposomal amphotericin B (AmBisome(®); LAmB) is a unique lipid formulation of amphotericin B. LAmB is a standard of care for a wide range of medically important opportunistic fungal pathogens. LAmB has a significantly improved toxicity profile compared with conventional amphotericin B deoxycholate (DAmB). Despite nearly 20 years of clinical use, the pharmacokinetics and pharmacodynamics of this agent, which differ considerably from DAmB, remain relatively poorly understood and underutilized in the clinical setting. The molecular pharmacology, preclinical and clinical pharmacokinetics, and clinical experience with LAmB for the most commonly encountered fungal pathogens are reviewed. In vitro, experimental animal models and human clinical trial data are summarized, and novel routes of administration and dosing schedules are discussed. LAmB is a formulation that results in reduced toxicity as compared with DAmB while retaining the antifungal effect of the active agent. Its long terminal half-life and retention in tissues suggest that single or intermittent dosing regimens are feasible, and these should be actively investigated in both preclinical models and in clinical trials. Significant gaps remain in knowledge of pharmacokinetics and pharmacodynamics in special populations such as neonates and children, pregnant women and obese patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s40265-016-0538-7

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Bone marrow transplant
Szer, J. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,373
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,705
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Phase transitions in phospholipid vesicles Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol
Papahadjopoulos, D., Jacobson, K., Nir, S., & Isac, I. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90314-3 · Cited by 998
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 907
Amphotericin B formulations: a comparative review of efficacy and toxicity
Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
Cornely, O. A., Maertens, J. A., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heußel, C. P., Lortholary, O., Rieger, C. T., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 744

Show all 119 references

Research works printed but not linked: 1

Joint Formulary Committee. British National Formulary. 70th ed. London: BMJ Group and Pharmaceutical Press;2015.

Sorted by citations

Items 301–400 of 538

Interaction between Antifungal Isoxazolo[3,4-b]Pyridin 3(1H)-One Derivatives and Human Serum Proteins Analyzed with Biomimetic Chromatography and QSAR Approach
Ciura, K., Fedorowicz, J., Kapica, H., Pastewska, M., Sawicki, W., & Sączewski, J. (2021) · Processes · doi:10.3390/pr9030512 · Cited by 7
Anfotericina B liposomal en el tratamiento de la leishmaniasis visceral
Monge‐Maíllo, B., & López‐Vélez, R. (2021) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2021.04.002 · Cited by 7
Evaluation of release and pharmacokinetics of hexadecylphosphocholine (miltefosine) in phosphatidyldiglycerol-based thermosensitive liposomes
Rysin, A., Paal, M., Lokerse, W. J. M., Wedmann, B., Hossann, M., Vogeser, M., Winter, G., & Lindner, L. H. (2021) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2021.183698 · Cited by 7
Comparative EPR spectroscopy analysis of amphotericin B and miltefosine interactions with Leishmania, erythrocyte and macrophage membranes
Alonso, L., Mendanha, S. A., Gomes, R. S., Dorta, M. L., & Alonso, A. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105859 · Cited by 7
The polyene antifungal candicidin is selectively packaged into membrane vesicles in Streptomyces S4
Blackburn, S. A., Shepherd, M., & Robinson, G. K. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-02906-w · Cited by 6
Antimicrobial Pharmacokinetic Considerations in Extracorporeal Membrane Oxygenation
Johns, K., Eschenauer, G. A., Clark, A., Butler, S. O., & Dunham, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123554 · Cited by 6
Engineering Delivery Technologies for Optimizing mRNA Vaccines
Gu, T., Yan, X., & Liu, S. (2025) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00032 · Cited by 7
A study of genomic complexity underlying multidrug resistance in Candida auris strains in Thailand
Opassathian, K., Boonmee, N., Swangkaew, S., Jenjaroenpun, P., Wongsurawat, T., Kruasuwan, W., Ngamskulrungroj, P., & Mitrpant, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-25386-6 · Cited by 6
Degradable Theranostic Polyurethane for Macrophage-Targeted Antileishmanial Drug Delivery
Bag, S., Seth, A., Ghosh, D., Datta, R., & De, P. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.4c01273 · Cited by 6
H-Dots: Renal Clearable Zwitterionic Nanocarriers for Disease Diagnosis and Therapy
Paranjape, S., Choi, K. Y., Kashiwagi, S., & Choi, H. S. (2025) · Langmuir · doi:10.1021/acs.langmuir.4c04372 · Cited by 6
Role of liposomal amphotericin B in intensive care unit: an expert opinion paper
Bussini, L., Bartoletti, M., Bassetti, M., Cortegiani, A., PASCALE, G. D., Rosa, F. G. D., Falcone, M., Giannella, M., Girardis, M., Grossi, P., et al. (2025) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-025-00236-z · Cited by 9
Microfluidic technologies in tumour metabolism
Doherty, M., Wang, T., Lamprou, D. A., & Coulter, J. A. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122370 · Cited by 6
Dosing implications for liposomal amphotericin B in pregnancy
O’Grady, N., McManus, D. S., Briggs, N., Azar, M. M., Topal, J. E., & Davis, M. W. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2784 · Cited by 6
The alternating 50 Hz magnetic field depending on the hydrophobicity of the strain affects the viability, filamentation and sensitivity to drugs of Candida albicans
Sztafrowski, D., Muraszko, J., Jasiura, A., Bryk, P., Urbanek, A. K., & Krasowska, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291438 · Cited by 6
Evaluation of Efficacy and Safety of Topical Nanoliposomal Amphotericin B 0.4% Gel as a Potential Treatment for Onychomycosis: An Interventional Pilot Clinical Study
Firooz, A., Zamani, S., Ghadrei, A., Ayatollahi, A., Tamimi, P., Khamesipour, A., Jafari, M., & Fattahi, A. (2023) · Dermatologic Therapy · doi:10.1155/2023/9955124 · Cited by 6
All hands on Dec: Treating cryptococcosis with dectin decorated liposomes loaded with antifungals
Pham, T., Shi, R., Ambati, S., Meagher, R. B., & Lin, X. (2024) · iScience · doi:10.1016/j.isci.2024.110349 · Cited by 6
Liposomal Drug Delivery: Progress, Clinical Outlook, and Ongoing Challenges
Tiwari, C., Tomer, J., & Kumar, D. (2024) · Recent Advances in Drug Delivery and Formulation · doi:10.2174/0126673878300031240703070511 · Cited by 9
Nasal Gel Loaded with Amphotericin Nanotransferosomes as Antifungal Treatment for Fungal Sinusitis
Hosny, K. M., & Alhakamy, N. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010035 · Cited by 6
Synthesis, Pharmacokinetics, and Toxicity of Nano-Drug Carriers
Tedla, N., Ruiz, J., Mody, V. V., Wang, X., & Bhave, V. (2021) · Springer eBooks · doi:10.1007/978-981-33-4497-6_3 · Cited by 6
Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?
Drewett, G. P., Copaescu, A. M., DeLuca, J., Holmes, N. E., & Trubiano, J. A. (2021) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-021-00582-x · Cited by 6
Structurally Related Liposomes Containing N-Oxide Surfactants: Physicochemical Properties and Evaluation of Antimicrobial Activity in Combination with Therapeutically Available Antibiotics
Battista, S., Bellio, P., Fagnani, L., Allegritti, E., Nazzicone, L., Galantini, L., Celenza, G., & Giansanti, L. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00609 · Cited by 6
Inconsistent efficacy of water‐soluble amphotericin B for the treatment of Macrorhabdus ornithogaster in a budgerigar (Melopsittacus undulatus) aviary
Baron, H., Stevenson, B. C., & Phalen, D. N. (2020) · Australian Veterinary Journal · doi:10.1111/avj.12936 · Cited by 6
Making in vitro release and formulation data AI-ready: A foundation for streamlined nanomedicine development
Yanes, D., Mead, H., Mann, J., Röding, M., Paraskevopoulou, V., Alexander, C., Parhizkar, M., Twycross, J., & Zelzer, M. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100393 · Cited by 5
Severe acute refractory hyperkalaemia associated with liposomal amphotericin B infusion
von Kreijfelt, G., Davidson, L., Holtrust, Y. J., Arends, M. L., & Zwaveling, J. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.106536 · Cited by 5
In Vivo Confocal Microscopy and Anterior Segment Optical Coherence Tomography in Optimizing Diagnosis and Therapeutic Management in Fungal Keratitis: Case Reports and Literature Review
Gheorghe, A. G., Arghirescu, A. M., Marinescu, M. C., Onofrei, A. G., Pop, D. M., Voinea, L., & Ciuluvica, R. C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14228066 · Cited by 5
Long-acting lipid-based nanomedicines: rethinking from structure-based rational design to in vivo fate evaluation
Tang, Y., Lu, S., Liang, W., He, Y., Hao, J., Xu, W., Sun, Y., & Zhan, C. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114465 · Cited by 7
Wound dressing using graphene quantum dots: a proof of concept
Martins, V. G. F. C., Alencar, L. M. R., Souza, P. F. N., Lorentino, C. M. A., Frota, H. F., dos Santos, A. L. S., Piperni, S. G., Morandi, V., Rodrigues, V. G., Pereira, J. X., et al. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00612-3 · Cited by 5
Transdermal delivery of amphotericin B using deep eutectic solvents for antifungal therapy
Xie, B., Jiang, Q., Zhu, F., Lai, Y., Zhao, Y., He, W., & Yang, P. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110508 · Cited by 6
Enhanced antifungal activity of siRNA-loaded anionic liposomes against the human pathogenic fungus Aspergillus fumigatus
Yu, Y., Vogel, T., Hirsch, S., Gröll, J., Albrecht, K., & Beilhack, A. (2024) · Nanoscale · doi:10.1039/d4nr03225j · Cited by 5
Nanoliposomes as Drug Delivery Systems for Antifungal Therapy
Alobeidat, S., & Athamneh, T. (2022) · Precision Nanomedicine · doi:10.33218/001c.56154 · Cited by 5
Incidence of acute kidney injury in dogs with systemic mycotic infections treated with amphotericin B (1996-2020)
Chan, J. C., Dear, J. D., Palm, C. A., & Reagan, K. L. (2023) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16728 · Cited by 5
Drug delivery breakthrough technologies – A perspective on clinical and societal impact
Bittner, B., Sánchez-Félix, M., Lee, D., Koynov, A. A., Horvath, J. D., Schumacher, F. F., & Matoori, S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.034 · Cited by 5
Nanomedicines for the Treatment of Systemic Candidiasis
Rana, D., Salave, S., Rawat, G., & Benival, D. M. (2023) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-39020-3_4 · Cited by 6
State of the art in pediatric nanomedicines
Abedin, S., & Adeleke, O. A. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01532-x · Cited by 5
Liposomal dual delivery systems in visceral leishmaniasis enhance the synergistic effects of combination therapy: A promise for the future
Hazra, R., Kar, A., & Mahapatra, S. K. (2024) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/apjtm.apjtm_567_23 · Cited by 5
Imaging of pulmonary cryptococcosis with consolidations or diffuse infiltrates suggests longer clinical treatment in non-HIV patients
Su, Y., Zhang, Y., Wang, Q., Hu, B., & Pan, J. (2024) · BioScience Trends · doi:10.5582/bst.2024.01288 · Cited by 5
Efficacy of two novel antifungal lipopeptides, AF4 and AF5 of bacillomycin D family in murine models of invasive candidiasis, cryptococcosis, and aspergillosis
Paul, R. A., Madduri, M., Kashyap, N., Ramesh, S., Rudramurthy, S. M., & Roy, U. (2024) · Apmis · doi:10.1111/apm.13506 · Cited by 5
Evolving nanotechnological trends in the management of mycotic keratitis
Rai, M., Grupenmacher, A. T., Ingle, A. P., Paralikar, P., Gupta, I. R., & Alves, M. (2019) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2018.5416 · Cited by 5
Evaluation of renal effects of liposomal amphotericin B in children with malignancies with KDIGO and RIFLE criteria.
Devrim, F., Çağlar, İ., Acar, S. O., Akkuş, Ş., Dinçel, N., Yılmaz, E., Tahta, N., Demirağ, B., Karapınar, T., Gözmen, S., et al. (2021) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2021.06.007 · Cited by 3
Pulmonary mucormycosis in systemic lupus erythematosus: successful management of a case along with review of literature
Kharbanda, R., Mehndiratta, A., Chatterjee, R., Marak, R. S. K., & Aggarwal, A. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05941-y · Cited by 5
Antifungal effect of triclosan on Aspergillus fumigatus: quorum quenching role as a single agent and synergy with liposomal amphotericin-B
Tamimi, R., Kyazze, G., & Keshavarz, T. (2022) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-022-03325-1 · Cited by 5
Nanovesicles for tumor-targeted drug delivery
Karpuz, M., İlhan, M., Gülteki̇n, H. E., Özgenç, E., Şenyiğit, Z. A., & Gündoğdu, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00017-1 · Cited by 5
High-throughput assay for effect screening of amphotericin B and bioactive components on filamentous Candida albicans
Haslene‐Hox, H., Nærdal, G. K., Mørch, Y. A., Hageskal, G., Tøndervik, A., Turøy, A. V., Johnsen, H., Klinkenberg, G., & Sletta, H. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15770 · Cited by 4
Advances in anti-invasive fungal drug delivery systems
Ma, Z., Wang, X., & Li, C. (2023) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2023-0030 · Cited by 5
Trendings of amphotericin B-loaded nanoparticles as valuable chemotherapeutic approaches against leishmaniasis
Oliveira, S. S. D. C., Branquinha, M. H., Cruz, M. D. S. P. E., dos Santos, A. L. S., & Sangenito, L. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821100-7.00014-5 · Cited by 5
[Therapeutic effect of low-dose omeprazole vs. standard-dose ranitidine in mild to moderate reflux esophagitis].
Kim, J. W., Kim, H., Lee, D. K., Suk, K. T., Kim, J. M., Baik, S. K., Kwon, S. O., & Cho, M. Y. (2004) · PubMed · Cited by 5
Harnessing nanotechnology to combat antimicrobial-resistant pathogens: a multidisciplinary approach to strengthen global public health defense systems
Oso, T. A., Okesanya, O. J., Adebayo, U. O., Ayelaagbe, O. B., Obadeyi, K. B., Ogunmuyiwa-James, M. E., Ahmed, M. M., Yahaya, A. K., Musa, S. S., Chukwu, C. N., et al. (2025) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-025-00707-w · Cited by 6
In Vitro and Ultrastructural Evaluation of the Cytotoxic and Antileishmanial Activities of Thiosemicarbazone Compounds Against Promastigotes and Axenic Amastigotes of Leishmania infantum
da Silva, J. W. L. M., Diniz, A. R. A. D. R., de Araújo, A. R., Gonçalves, G. G. A., Veras, D. L., Cavalcante, M. K. D. A., Sandes, J. M., Filho, I. J. D. C., Marques, D. S. C., de Lima, M. D. C. A., et al. (2025) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed10110325 · Cited by 4
Targeting strategies, clinical translation and translational barriers of liposomes in cancer therapy
Su, J., Na, J., Yang, Q., Huang, H., Xiao, L., Wu, P., & Zhong, L. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.153155 · Cited by 7
Advances in Liposomes-Based-Therapeutics as Cutting-Edge for Ocular Fungal Infections: An Updated Review
Mehendiratta, H., Singh, S., Sharma, N., Kishore, L., Dwivedi, M., & Rani, A. (2024) · BioNanoScience · doi:10.1007/s12668-024-01447-4 · Cited by 5
Advancing cryptococcal treatment: The role of nanoparticles in mitigating antifungal resistance
Lathakumari, R. H., Vajravelu, L. K., Satheesan, A., & Thulukanam, J. (2024) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2024.100323 · Cited by 4
Pharmacokinetic study of AmB-NP-GR: A new granule form with amphotericin B to treat leishmaniasis and fungal infections
Tadini, M. C., Fernandes, F. S., Ozelin, S. D., de Melo, M. R. S., Mansur, A. L., de Toledo, T. B., de Albuquerque, N. C. P., Tavares, D. C., Marquele‐Oliveira, F., & de Oliveira, A. R. M. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106173 · Cited by 4
Sinonasal mucormycosis and liposomal amphotericin B: A quest for dose optimization
Gupta, P., Kajal, S., Naeem, S. S., Kairo, A. K., Ahmed, A., Verma, P., & Saini, A. K. (2022) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_644_21 · Cited by 4
Application of Physiologically Based Pharmacokinetic Model to Compare the Biodistribution of Liposomal Amphotericin B With Conventional Amphotericin B Deoxycholate in Humans
Zhang, X., Yang, Y., Wang, M., Qi, H., Li, C., & Zhao, L. (2024) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2406 · Cited by 4
Modulating the immune response with liposomal delivery
Nardo, D., Henson, D. M., Springer, J. E., & Venditto, V. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816705-2.00006-0 · Cited by 4
Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection
Calvo, A., Moreno, E., Clemente, U., Pérez, E., Larrea, E., Sanmartín, C., Irache, J. M., & Espuelas, S. (2021) · Nanoscale · doi:10.1039/d1nr03797h · Cited by 4
Anti-leishmanial compounds from microbial metabolites: a promising source
da Cunha, A. F. S., Oliveira, Y. L. D. C., Dolabella, S. S., Scher, R., Souto, E. B., López, J. A., & Jain, S. A. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11610-6 · Cited by 4
Paracoccidioides brasiliensis plasma membrane characterization by EPR spectroscopy and interactions with amphotericin B, miltefosine and nerolidol
Alonso, L., Rocha, O. B., Júnior, M. A. B. D. C., Soares, C. M. D. A., Pereira, M., & Alonso, A. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2093274 · Cited by 4
Stability testing parameters of nanoscaled product development
Chaurasiya, A., Gorajiya, A., & Nirmal, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85041-4.00010-x · Cited by 4
Intracellular pH-Regulating Nanoparticles to Improve Anticancer Drug Efficacy for Cancer Treatment
Lee, T., Kim, K. S., & Na, K. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00952 · Cited by 4
New piericidin rhamnosides as potentiators of amphotericin B activity against Candida albicans produced by actinomycete strain TMPU-A0287
Yagi, A., Yamaguchi, Y., Kawasaki, K., Usui, E., Yamazaki, H., & Uchida, R. (2022) · The Journal of Antibiotics · doi:10.1038/s41429-022-00581-z · Cited by 4
The Elevated Endogenous Reactive Oxygen Species Contribute to the Sensitivity of the Amphotericin B-Resistant Isolate of Aspergillus flavus to Triazoles and Echinocandins
Liang, T., Chen, W., Yang, X., Wang, Q., Wan, Z., Li, R., & Liu, W. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.680749 · Cited by 5
Regulatory, safety, and toxicological concerns of nanomaterials with their manufacturing issues
Aulić, S., Laurini, E., Marson, D., Skoko, N., Fermeglia, M., & Pricl, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85050-6.00002-5 · Cited by 3
Raman Imaging of an Amphotericin B Potentiator in Single-Cell Saccharomyces cerevisiae
Miyake, R., Ando, M., Kobayashi, K., Nagai, K., Ohshiro, T., Tomoda, H., & Takeyama, H. (2025) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5c02477 · Cited by 3
Liposomal amphotericin B prophylaxis in paediatrics: a systematic review
Thorley, E., Hatch, J., Li, M. K., Mashida, S. N., Castagnola, E., Mesini, A., Lehrnbecher, T., Groll, A. H., Warris, A., & Ferreras-Antolin, L. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf171 · Cited by 3
Combating Antimicrobial Resistance: Role of Key Stakeholders with Focus on the Pharmaceutical Sector
Sharma, S., Satyaseela, M. P., Burri, R., Palakodeti, R., & Pamarthy, D. (2025) · Pharmaceutical Medicine · doi:10.1007/s40290-025-00572-z · Cited by 4
Combination of isobavachalcone and amphotericin B has antifungal effect against Cryptococcus neoformans and protects host tissue damage by inhibiting ferroptosis
Qian, W., Liu, N., Lu, J., Liu, Q., Chen, S., & Wang, T. (2025) · Virulence · doi:10.1080/21505594.2025.2543981 · Cited by 3
Efficacy assessments of EL219, a next-generation polyene antifungal, in immunosuppressed mice infected with drug-sensitive and drug-resistant Aspergillus isolates
Youssef, E. G., Gebremariam, T., Gu, Y., Patterson, H. P., Alkhazraji, S., Elsayed, T., Wiederhold, N. P., & Ibrahim, A. S. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01400-25 · Cited by 3
Invasive Pulmonary Aspergillosis in Non-Neutropenic Patients: An Evolving Clinical Paradigm
Morena, R., Morrone, H. L., Serapide, F., & Russo, A. (2025) · Diagnostics · doi:10.3390/diagnostics16010034 · Cited by 3
Searching for Conjugates as New Structures for Antifungal Therapies
Muszalska-Kolos, I., & Dwiecki, P. M. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01750 · Cited by 3
NMR and molecular simulation studies on the structure elucidation of the amphotericin B ion channel using 13 C and 19 F labelling
Umegawa, Y., Tsuchikawa, H., Shinoda, W., & Murata, M. (2024) · Organic & Biomolecular Chemistry · doi:10.1039/d4ob01468e · Cited by 3
Liposomal Amphotericin B-induced Cardiac Arrhythmias in Infantile Visceral Leishmaniasis: A Case Report
Syridou, G., Karagiannidou, S., Papakonstantinou, M. E., Peteinelli, M. M., Giannakopoulos, K., & Papaevangelou, V. (2025) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000005015 · Cited by 3
TRIAZOLE RESISTANCE IN ASPERGILLUS FUMIGATUS-A COMPREHENSIVE REVIEW
Wadhwa, K., & Kaur, H. (2022) · Journal of Microbiology Biotechnology and Food Sciences · doi:10.55251/jmbfs.4159 · Cited by 3
Nanostructured drug delivery approaches for fungal infections
Bayat, F., Mehryab, F., Akhlaghi, S., & Haeri, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90792-7.00006-3 · Cited by 3
Comparing Invasive Pulmonary Aspergillosis Mortality Between Liposomal Amphotericin B and Voriconazole in Patients With Hematological Malignancy or Hematopoietic Stem Cell Transplantation
Mahmoud, E., Alzahrani, M., Loutfi, S. I., AlQahtani, H., Bosaeed, M., Ahmed, A., Alahmari, B., Alsadi, H. M., Ahmed, M., & Dhoayan, M. A. (2022) · Cureus · doi:10.7759/cureus.31762 · Cited by 3
Development of Amphotericin B Decorated Gold Nanoparticles as a Promising Antileishmanial Nanoconjugate
Sharma, K., Shah, J., Singh, S., & Sengupta, S. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00835 · Cited by 3
In vitro activity of nanoliposomal amphotericin B against terbinafine-resistant Trichophyton indotineae isolates
Nosratabadi, M., Akhtari, J., Jaafari, M. R., Yahyazadeh, Z., Shokohi, T., Haghani, I., Farmani, P., Barough, R. E., Badali, H., & Abastabar, M. (2024) · International Microbiology · doi:10.1007/s10123-024-00617-4 · Cited by 3
Parenteral Drug Delivery
Alam, M. I., & Yadav, A. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-4970-6_4 · Cited by 3
A cell wall-targeting urease-derived peptide as a potential antifungal agent against Candida species
Perin, A. P. A., Reuwsaat, J. C. V., Motta, H., Lopes, F. C., Grahl, M. V. C., Tavanti, A. G., Vainstein, M. H., Staats, C. C., Carlini, C. R., Ligabue‐Braun, R., et al. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100399 · Cited by 3
Targeting Azole-Resistant Candida albicans: Tetrapeptide Tuftsin-Modified Liposomal Vaccine Induces Superior Immune Protection
Khan, M. A., Khan, A., Alnuqaydan, A. M., Albutti, A., Alharbi, B. F., & Owais, M. (2025) · Vaccines · doi:10.3390/vaccines13060630 · Cited by 3
Hyperphosphatemia in an 11-year-old girl with acute myeloid leukemia: Answers
Albersen, M., Bökenkamp, A., Schotman, H. H. M., & Smetsers, S. E. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-4101-5 · Cited by 3
DRESS Syndrome Associated with Liposomal Amphotericin-B in a Kidney Transplant Patient: A Case Report
Charfi, O., Hammamia, S. B., Aouinti, I., Kaabi, W., Kastalli, S., Daghfous, R., Aïdli, S. E., Lakhoua, G., & Zaïem, A. (2021) · Current Drug Safety · doi:10.2174/1574886316666210727145646 · Cited by 3
Regulated Bioanalysis of Liposomal Amphotericin B to Support Pharmacokinetic Studies of Liposomal Drugs
Zhang, X., Ji, Y., Liu, J., Liu, J., Li, C., Wang, L., Meng, M., & Zhao, L. (2022) · Bioanalysis · doi:10.4155/bio-2021-0281 · Cited by 3
In Silico Research of New Therapeutics Rotenoids Derivatives against Leishmania amazonensis Infection
Vicente-Barrueco, A., Román, Á., Téllez, T. R., & Centeno, F. (2022) · Biology · doi:10.3390/biology11010133 · Cited by 3
Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches
Selby, P., Warner, M. S., Peake, S., Bardy, P., Hiwase, D., Singhal, D., Beligaswatte, A. M., Hahn, U., Roberts, J. A., Yeung, D. T. O., et al. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13988 · Cited by 3
Frontier in Antifungal Treatments Against Major Human Fungal Opportunistic Pathogen Candida Species and Medically Important Fungi
Soontorngun, N., Somboon, P., & Watchaputi, K. (2019) · Springer eBooks · doi:10.1007/978-3-030-21110-3_13 · Cited by 3
Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study
Obata, Y., Takazono, T., Tashiro, M., Ota, Y., Wakamura, T., Takahashi, A., Sato, K., Miyazaki, T., Nishino, T., & Izumikawa, K. (2021) · Clinical and Experimental Nephrology · doi:10.1007/s10157-020-02004-5 · Cited by 3
An Update on Fungal Orbital Infections
Chiou, C. A., & Yoon, M. K. (2022) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000407 · Cited by 2
Modulating Aspergillus fumigatus biofilm formation: Antifungal-induced alterations in conidium-abiotic surface interactions
Tamimi, R., Kyazze, G., & Keshavarz, T. (2024) · Fungal Interactions · doi:10.1016/j.funint.2024.100002 · Cited by 2
A convenient and rapid LC-MS/MS method for determination of free and liposomal amphotericin B in human plasma by simultaneous separation using SPE
Jin, Y., Wu, B., Gong, Y., Wei, H., Ma, R., Wang, Y., Yuan, M., & Xu, H. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116884 · Cited by 2
Development and evaluation of niosomes containing amphotericin B and clove oil for the improvement of antifungal and antiparasitic therapies
do Nascimento, T., Cardoso, V. D. S., Santos‐Oliveira, R., Barreto-Vieira, D. F., Vermelho, A. B., & Ricci‐Júnior, E. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107243 · Cited by 2
Spatial Pharmacokinetic and Pharmacodynamic Modeling in Airway Mucus
Guo, Y., Yin, J., Yonucu, S., Knibbe, C. A. J., Guo, T., & van Hasselt, J. G. C. (2025) · Clinical Pharmacokinetics · doi:10.1007/s40262-025-01575-4 · Cited by 2
The recombinant protein of scorpion venom phospholipase A2 exhibits potential anti-leishmanial activity
Soltan‐Alinejad, P., Ramezani, A., Asgari, Q., Alipour, H., Soltani, A., Bahreini, M. S., Nıkbakhtzadeh, M. R., & Azizi, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-29796-4 · Cited by 2
Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios
Angelini, J., Ferin, S., Martini, L., Flammini, S., Tascini, C., & Giuliano, S. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00228-25 · Cited by 2
Safety and efficacy of echinocandin antifungal agents in Candida albicans endophthalmitis
Zhang, Y., Tang, Y. R., Zhou, Y., & Wu, H. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01670-25 · Cited by 2
Lipid-based nanocarriers for anticancer drug delivery: Mechanistic advances, translational challenges, and implications for generic development
Rahman, M. M., & Rahman, M. M. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108393 · Cited by 2
Nanotechnology based topical drug delivery systems for psoriasis addressing current strategies clinical progress and manufacturing challenges
BHOYAR, S., & Pethe, A. M. (2026) · Discover Nano · doi:10.1186/s11671-026-04727-y · Cited by 2
Lipid-based nanocarriers for antifungal drug delivery
Staniszewska, A., Kala, D., Kuryk, Ł., Borkowska, A. M., Kuma, S., & Staniszewska, M. (2026) · Discover Nano · doi:10.1186/s11671-026-04676-6 · Cited by 2
Antifungal PK/PD in the Critically Ill
Brüggemann, R. J. M., de Lange, D. W., & Alffenaar, J. C. (2017) · Springer eBooks · doi:10.1007/978-981-10-5336-8_11 · Cited by 2
OBEZ HASTALARDA ANTİMİKROBİYAL İLAÇ DOZLARI
Bahap, M., Ekinci, P. B., Bayraktar‐Ekincioglu, A., & Demirkan, K. (2019) · STED / Sürekli Tıp Eğitimi Dergisi · doi:10.17942/sted.598625 · Cited by 2

Authors: Stone, N. R. H., Bicanic, T., Salim, R., & Hope, W.
Affiliations: St George's, University of London (GB)
Royal Liverpool University Hospital (GB)
University of Liverpool (GB)
Corresponding author: Stone, Neil R. H.
ORCID: Stone, Neil R. H.
Bicanic, Tihana
Hope, William
Venue: Drugs
Publisher: Springer Science and Business Media LLC
Published: 2016-01-27
Volume: 76
Issue: 4
Pages: 485-500
ISSN: 0012-6667 (ISSN-L)
1179-1950
DOI: 10.1007/s40265-016-0538-7
PMC: PMC4856207
OpenAlex: W2298912458
Cited by: 537
References: 119
Citations by year: 2026: 52 · 2025: 81 · 2024: 73 · 2023: 61 · 2022: 73 · 2021: 60 · 2020: 55 · 2019: 40 · 2018: 16 · 2017: 23 · 2016: 1
FWCI: 4.10
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Drugs (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Wellcome Trust Strategic Award (Medical Mycology and Fungal Immunology) (RG12848-10)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords: liposomal amphotericin B, amphotericin B deoxycholate, pharmacokinetics, pharmacodynamics, antifungal agents, opportunistic fungal infection, drug toxicity, dosing regimen, intermittent dosing, neonates, pregnancy, obesity, molecular pharmacology
MeSH terms: Amphotericin B, Animals, Chemistry, Pharmaceutical, Clinical Trials as Topic, Deoxycholic Acid, Drug Combinations, Half-Life, Humans, Tissue Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks